Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysis

被引：0
|
作者：
Liberopoulos, E
Papavasiliou, E
Tzallas, C
Katopodis, K
Gouva, C
Christidis, D
Tselepis, A
Siamopoulos, K
Elisaf, M
机构：
[1] Univ Ioannina, GR-45110 Ioannina, Greece
[2] Univ Hosp Ioannina, Ioannina, Greece
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)91444-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [41] Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
    Tsimihodimos, V
    Kakafika, A
    Tambaki, AP
    Bairaktari, E
    Chapman, MJ
    Elisaf, M
    Tselepis, AD
    JOURNAL OF LIPID RESEARCH, 2003, 44 (05) : 927 - 934
  • [42] Platelet-Activating Factor Acetylhydrolase (PAF-AH): A Predictor of Adverse Event in Medically Treated CTEPH Patients?
    Quarck, R.
    Durand, H.
    Ninio, E.
    Delcroix, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S61 - S61
  • [43] PLATELET-ACTIVATING-FACTOR (PAF) ACETYLHYDROLASE ACTIVITY IN HUMAN SKIN AFTER ANTIGEN CHALLENGE
    TEAFORD, HG
    CHARLESWORTH, EN
    WOODARD, DS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 354 - 354
  • [44] Addition of platelet activating factor acetylhydrolase (PAF-AH) to organ preservation solutions decreases lung reperfusion injury.
    Marcus, KA
    Roberts, RF
    Darbinian, S
    Azatian, A
    Starnes, VA
    Barr, ML
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 43A - 43A
  • [45] SERUM PON1 AND HDL RELATED PAF-AH ENZYME ACTIVITIES IN CORONARY ARTERY DISEASE PATIENTS WITH HIGH CIRCULATING HDL LEVELS
    Kucuk, H. O.
    Kunak, T.
    Kucuk, U.
    Ulgen, A.
    Unlu, M.
    Abaci, A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S53 - S53
  • [46] Two novel mutations in the plasma platelet-activating factor acetylhydrolase (PAF-AH) gene identified in Japanese subjects
    Ishihara, M
    Nagano, M
    Iwasaki, T
    Kujiraoka, T
    Ishii, J
    Tsuji, M
    Ito, M
    Kumagai, T
    Egashira, T
    Hattori, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 330 - 330
  • [47] ADVANCED GLYCATION END PRODUCTS DECREASE PON1 GENE EXPRESSION AND INCREASE PAF-AH GENE EXPRESSION
    Yamamoto, Isamu
    Honda, Teruko
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 106 - 106
  • [48] PLATELET-ACTIVATING-FACTOR (PAF) CONCENTRATION AND PAF ACETYLHYDROLASE ACTIVITY IN CEREBROSPINAL-FLUID OF PATIENTS WITH SUBARACHNOID HEMORRHAGE
    HIRASHIMA, Y
    ENDO, S
    OHMORI, T
    KATO, R
    TAKAKU, A
    JOURNAL OF NEUROSURGERY, 1994, 80 (01) : 31 - 36
  • [49] Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group
    Benli, Erdal
    Bayrak, Ahmet
    Cirakoglu, Abdullah
    Bayrak, Tulin
    Noyan, Tevfik
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2017, 33 (11): : 572 - 577
  • [50] Endotoxin promotes elevation of biliary platelet-activating factor acetylhydrolase (PAF-AH) by altering hepatic paracellular permeability.
    King, JM
    Olson, MS
    FASEB JOURNAL, 2000, 14 (08): : A1461 - A1461
12345